PL379145A1 - Kompozycje i sposoby obejmujące związki gastryny - Google Patents
Kompozycje i sposoby obejmujące związki gastrynyInfo
- Publication number
- PL379145A1 PL379145A1 PL379145A PL37914504A PL379145A1 PL 379145 A1 PL379145 A1 PL 379145A1 PL 379145 A PL379145 A PL 379145A PL 37914504 A PL37914504 A PL 37914504A PL 379145 A1 PL379145 A1 PL 379145A1
- Authority
- PL
- Poland
- Prior art keywords
- diabetes
- compositions
- gastrin compounds
- gastrin
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/016660 WO2003100024A2 (en) | 2002-05-24 | 2003-05-27 | Treatment for diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL379145A1 true PL379145A1 (pl) | 2006-07-24 |
Family
ID=33488788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL379145A PL379145A1 (pl) | 2003-05-27 | 2004-05-27 | Kompozycje i sposoby obejmujące związki gastryny |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1648495A2 (https=) |
| JP (1) | JP2007513059A (https=) |
| CN (1) | CN1829528A (https=) |
| AU (1) | AU2004243541A1 (https=) |
| BR (1) | BRPI0410710A (https=) |
| CA (1) | CA2527186A1 (https=) |
| MX (1) | MXPA05012605A (https=) |
| NO (1) | NO20055582L (https=) |
| PL (1) | PL379145A1 (https=) |
| RU (1) | RU2005140518A (https=) |
| WO (1) | WO2004105780A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL156828A0 (en) | 2001-01-12 | 2004-02-08 | Waratah Pharmaceuticals Inc | Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes |
| EP1837031B1 (en) | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
| US7560425B2 (en) | 2002-06-07 | 2009-07-14 | Waratah Pharmaceuticals Inc. | Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| US20090202494A1 (en) * | 2004-01-30 | 2009-08-13 | Antonio Cruz | Combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| WO2008106779A1 (en) * | 2007-03-02 | 2008-09-12 | Waratah Pharmaceuticals Inc. | Gastrin compound for diabetes treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558952B1 (en) * | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
| DE69431212T2 (de) * | 1994-01-24 | 2003-04-10 | The General Hospital Corp., Boston | Behandlung von diabetes |
| IL156828A0 (en) * | 2001-01-12 | 2004-02-08 | Waratah Pharmaceuticals Inc | Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes |
| KR20050074492A (ko) * | 2002-10-22 | 2005-07-18 | 와라타 파마수티컬즈, 인크. | 당뇨병의 치료 |
-
2004
- 2004-05-27 PL PL379145A patent/PL379145A1/pl not_active Application Discontinuation
- 2004-05-27 MX MXPA05012605A patent/MXPA05012605A/es not_active Application Discontinuation
- 2004-05-27 WO PCT/CA2004/000769 patent/WO2004105780A2/en not_active Ceased
- 2004-05-27 BR BRPI0410710-1A patent/BRPI0410710A/pt not_active IP Right Cessation
- 2004-05-27 EP EP04737749A patent/EP1648495A2/en not_active Withdrawn
- 2004-05-27 CN CNA200480022042XA patent/CN1829528A/zh active Pending
- 2004-05-27 AU AU2004243541A patent/AU2004243541A1/en not_active Withdrawn
- 2004-05-27 CA CA002527186A patent/CA2527186A1/en not_active Abandoned
- 2004-05-27 JP JP2006529497A patent/JP2007513059A/ja active Pending
- 2004-05-27 RU RU2005140518/15A patent/RU2005140518A/ru not_active Application Discontinuation
-
2005
- 2005-11-25 NO NO20055582A patent/NO20055582L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1648495A2 (en) | 2006-04-26 |
| RU2005140518A (ru) | 2007-07-10 |
| BRPI0410710A (pt) | 2006-06-13 |
| WO2004105780A2 (en) | 2004-12-09 |
| AU2004243541A1 (en) | 2004-12-09 |
| CN1829528A (zh) | 2006-09-06 |
| CA2527186A1 (en) | 2004-12-09 |
| JP2007513059A (ja) | 2007-05-24 |
| MXPA05012605A (es) | 2006-02-22 |
| NO20055582D0 (no) | 2005-11-25 |
| NO20055582L (no) | 2006-02-27 |
| WO2004105780A3 (en) | 2005-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL171902A0 (en) | Compositions comprising gastrin compounds and their use in diabetes | |
| PL379145A1 (pl) | Kompozycje i sposoby obejmujące związki gastryny | |
| GB0300804D0 (en) | Compounds and their use | |
| GB0300805D0 (en) | Compounds and their use | |
| GB0301143D0 (en) | Compounds and their use | |
| GB0317133D0 (en) | Compounds and their use | |
| GB0311167D0 (en) | Composition and use | |
| GB0311166D0 (en) | Composition and use | |
| GB0311164D0 (en) | Composition and use | |
| GB0311163D0 (en) | Composition and use | |
| GB0301401D0 (en) | Composition and use | |
| GB0325237D0 (en) | Composition and use | |
| GB0325238D0 (en) | Composition and use | |
| GB0325239D0 (en) | Composition and use | |
| GB0325241D0 (en) | Composition and use | |
| GB0317281D0 (en) | Compounds and their use | |
| GB0309320D0 (en) | Compounds and their use | |
| GB0310333D0 (en) | Compounds and their use | |
| GB0322011D0 (en) | Compounds and their use | |
| GB0321442D0 (en) | Compounds and their use | |
| GB0321301D0 (en) | Compounds and their use | |
| GB0320064D0 (en) | Compounds and their use | |
| GB0320062D0 (en) | Compounds and their use | |
| GB0317283D0 (en) | Compounds and their use | |
| GB0310471D0 (en) | Compounds and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |